Important DatesAbstract Submission and Early Registration have closed.
Advance Registration Deadline:
11 October, 2017
Cancellation and Refund Deadline:
8 September, 2017
THE ISSCR INTERNATIONAL SYMPOSIA RETURN TO CHINA!
The International Society for Stem Cell Research (ISSCR) and the Guangzhou Institutes of Biomedicine and Health (GIBH) present Stem Cells: The Next Generation, an ISSCR International Symposium, 10-12 November, 2017. This forward-thinking conference will explore the development of stem cell therapy. From the foundational to the translational, the ISSCR continues to bring you the latest information from the field’s leading minds: the "next generation" of stem cell research and therapeutic application.
- Stem Cell State and Differentiation
- Organoids and Disease Modeling
- Cell-Based Therapies
- Ethics of Genome Engineering
WHAT TO EXPECT
The International Society for Stem Cell Research (ISSCR) and the Guangzhou Institute for Biological Health (GIBH) are proud to present an exciting scientific program in an engaging, intimate atmosphere. The meeting will begin with a keynote lecture on Friday, 10 November and conclude on Sunday, 12 November. There will be opportunities for interactions among all levels of attendees. Lecture sessions will be supplemented with opportunities for abstract-selected talks, poster teasers presentations, and social and networking events
WHO SHOULD ATTEND?
Academic, industry and clinical researchers interested in stem cell biology and its therapeutic applications are encouraged to attend and share their research. Attendees will hear from leaders in the field and benefit from the convivial atmosphere and open exchange of ideas found at this symposium.
WHAT SETS INTERNATIONAL SYMPOSIA APART?
International Symposia are where the world's leading minds are building the future of stem cell science. They are focused meetings that bring together approximately 400 attendees,100 posters and exhibitors with innovative technologies. The goal is to expand the educational reach of stem cell research, making it more accessible for stem cell scientists from around the world.